Literature DB >> 7104587

DDAVP for adult enuresis--a preliminary report.

P D Ramsden, J R Hindmarsh, D A Price, W K Yeates, J D Bowditch.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 7104587     DOI: 10.1111/j.1464-410x.1982.tb06970.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


× No keyword cloud information.
  9 in total

1.  Desmopressin for bed wetting: length of treatment, vasopressin secretion, and response.

Authors:  J H Evans; S R Meadow
Journal:  Arch Dis Child       Date:  1992-02       Impact factor: 3.791

Review 2.  Urinary incontinence in women: have we anything new to offer?

Authors:  L Cardozo
Journal:  BMJ       Date:  1991-12-07

Review 3.  Hyponatremia in patients with nocturnal enuresis treated with DDAVP.

Authors:  W L Robson; J P Nørgaard; A K Leung
Journal:  Eur J Pediatr       Date:  1996-11       Impact factor: 3.183

4.  Enuresis at 25.

Authors:  R C Feneley
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-14

5.  Use of three specific radioimmunoassays in measuring neurohypophysial hormone content and plasma concentrations of vasopressin, oxytocin and DDAVP in rats after prolonged infusion of DDAVP.

Authors:  S Lundin; P Melin; H Vilhardt
Journal:  Experientia       Date:  1985-07-15

Review 6.  Side effects and complications of treatment with desmopressin for enuresis.

Authors:  W L Robson; A K Leung
Journal:  J Natl Med Assoc       Date:  1994-10       Impact factor: 1.798

7.  Primary nocturnal enuresis and desmopressin treatment: do psychosocial factors affect outcome?

Authors:  R W Dittmann; S Wolter
Journal:  Eur Child Adolesc Psychiatry       Date:  1996-06       Impact factor: 4.785

8.  Comparison of intranasal and oral desmopressin for nocturnal enuresis.

Authors:  A Fjellestad-Paulsen; S Wille; A S Harris
Journal:  Arch Dis Child       Date:  1987-07       Impact factor: 3.791

Review 9.  Current concepts in the treatment of disorders of micturition.

Authors:  K E Andersson
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.